Skip to main content

May 2021

academics

 

Clinical research courses

Job for Pharmacist under the control of DMHO

FOR RECRUITMENT OF HUMAN RESOURCES UNDER CONTRACT BASIS TO WORK IN PRIMARY HEALTH CENTRES UNDER THE CONTROL OF DM&HO, ANANTHAPURAMU

Post  : Pharmacist

Career for M.Pharm, B.Pharm, D.Pharm as Operation Executive at Apollo Pharmacies Limited

Apollo Pharmacy is a leading retail chain of pharmacy and unit of Apollo Hospitals Enterprise Ltd. Asia's largest healthcare group. Our growing Retail Pharmacy network touches lives across the length and breadth of the India and we serve 150000+ customers a day. With over 30 years of retailing experience, customer-focused service and brand value our network spans out to 1550+ retail pharmacies through which we have been serving our customers for their healthcare needs 24x7.

Job for Professor, Assistant Professor, Associate Professor at Danteswari College of Pharmacy

Danteswari College of Pharmacy is established in the year 2019, at Borpadar, Near Jagdalpur, District: Bastar, Chhattisgarh under the aegis of Shaina Educational Trust. The institute offers 2 years D. Pharm (60 Seats), & 4 years B. Pharm (100 Seats)  courses in pharmacy from 2019-20 with approval from All India Council for Technical Education (AICTE), Pharmacy Council of India(PCI) & affiliated to Chattishgarh Swami Vivekanand Technical University (CSVTU).

Regional Centre for Biotechnology JRF Job - Life Sciences apply

Regional Centre for Biotechnology (RCB), an Institution of national importance established by the Department of Biotechnology, Govt. of India, with regional and global partnerships synergizing with the programmes of UNESCO. The primary focus of RCB is to provide world class education, training and conduct innovative research at the interface of multiple disciplines to create high quality human resource in disciplinary and interdisciplinary areas of biotechnology in a globally competitive research milieu.

Job for B.Pharm, M.Pharm in Production at Dr. Reddys Laboratories

Dr. Reddys Laboratories is an emerging global pharmaceutical company with proven research capabilities. The company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia. The Company conducts research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection.

Chemical R&D Jobs at Novick Bio-Sciences | M.Pharm, M.Sc apply

Novick Bio-Sciences is a rapidly-growing Contract Research and Development Organization (CRDO) providing chemistry and formulation development services to Global Pharmaceutical, Bio-tech, Agrochemical Research Organizations and Academics to help our customers achieve their goals.

Department : Chemical R&D

QA, QC, Analytical Research and Development Jobs at RAKSHIT PHARMACEUTICALS LTD

RAKSHIT PHARMACEUTICALS LTD., is an integrated API manufacturing company. Rakshit has emerged as a dependable and strong manufacturer of key APIs & intermediates for global markets. The company is looking for result oriented and dynamic personnel for its Rakshit Group at Vizag.

Walk in Interview for M.Pharm at Vital Pharma

Vital Therapeutics and Formulations Private Limited is an endeavour to offer trustworthy partnership comprising superior quality products and services par excellence in Contract Manufacturing, Animal Nutrition, Human Nutrition, Aquaculture and Vitamin pre-mixes.

Lupin Announces Achievement of Key Milestones for its Clinical Stage MEK Inhibitor Compound

Lupin Limited announced the achievement of key milestones for Lupins MEK inhibitor compound (LNP3794) that is planned for development by Boehringer Ingelheim in combination as potential targeted therapy for patients with difficult-to-treat cancers.

As part of the agreement, Lupin has received payment of USD 50 million from Boehringer Ingelheim
for achievement of key milestones.

Moderna Announces TeenCOVE Study of its COVID-19 Vaccine in Adolescents

Moderna, Inc a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Phase 2/3 study of its COVID-19 vaccine (mRNA-1273) in adolescents has met its primary immunogenicity endpoint, successfully bridging immune responses to the adult vaccination. In the study, no cases of COVID-19 were observed in participants who had received two doses of the Moderna COVID-19 vaccine using the primary definition.